Delivery Order SPE2DB22D3016-SPE2DB23FBRT9
Award Date
9/11/23
Potential Completion Date
10/2/23
Potential Value
$68K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $113,093.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ocrevus 300 MG/10 ML vials. Under this contract, Amerisourcebergen will deliver 10 ML vials of Ocrevus, a multiple sclerosis treatment, to a facility located in Conshohocken, Pennsylvania by September 12, 2023. The Defense Logistics Agency is the logistics combat support agency of the United States Department of Defense, responsible for worldwide logistics support in...
The Defense Logistics Agency awarded a $67,856 delivery order to Amerisourcebergen Drug Corporation for Ocrevus 300 MG/10 ML vials. Under the terms of the firm fixed price contract, Amerisourcebergen will deliver 10 ML vials of the multiple sclerosis treatment Ocrevus to a facility in Conshohocken, Pennsylvania. Performance will take place between July 14 and August 4, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to support the...
The Defense Logistics Agency awarded a $11,309.36 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ocrevus 300 MG/10 ML vials. The delivery order is for 10ML vials of Ocrevus, a multiple sclerosis treatment, to be delivered to a facility in Conshohocken, Pennsylvania by September 6, 2023. Amerisourcebergen will serve as the prime contractor to supply the pharmaceutical products to the Defense Logistics Agency, the logistics combat support agency of the United States...
The Defense Logistics Agency awarded a $45,237 delivery order to Amerisourcebergen Drug Corporation for Ocrevus 300 MG/10 ML vials. The firm fixed price order is valued at forty-five thousand two hundred thirty-seven dollars and will be performed in Conshohocken, Pennsylvania under the agency's Pharmaceutical Prime Vendor contract vehicle from August 3rd to August 24th, 2023. Amerisourcebergen will supply the multiple sclerosis treatment to the DLA, which manages the Department of Defense's...
The Defense Logistics Agency awarded a $67,856 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ocrevus 300 MG/10 ML vials. Under this order, Amerisourcebergen will deliver 10 ML vials of the multiple sclerosis treatment Ocrevus to a facility in Conshohocken, Pennsylvania. The order is funded by the Defense Logistics Agency and was awarded on September 27, 2023, with performance required by October 19, 2023. No set aside designation or subcontractors were identified....
The Defense Logistics Agency awarded a $113,093.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ocrevus 300 MG/10 ML vials. As the prime contractor, Amerisourcebergen will deliver 10 mL vials of Ocrevus, a multiple sclerosis treatment, to a facility in Conshohocken, Pennsylvania by October 17, 2023 under the terms of the order. The parent company, Amerisourcebergen Corporation, will perform the contract through its corporate office division. No set aside...
The Defense Logistics Agency awarded a $226,187.20 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ocrevus 300 mg/10 ml vials. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will deliver the multiple sclerosis treatment to a facility in Conshohocken, Pennsylvania by October 17, 2023 under the prime contract vehicle. No set aside designation or subcontractors were indicated. This supports the Defense Logistics Agency's mission to provide medical...
The Defense Logistics Agency awarded a $33,928 delivery order to Amerisourcebergen Drug Corporation for Ocrevus 300 MG/10 ML vials. Under this firm fixed price contract, Amerisourcebergen will deliver 4561904183 units of the multiple sclerosis treatment to a facility in Conshohocken, Pennsylvania by September 13th to support the Agency's medical supply needs. No set aside designation or subcontractors were identified. This order was placed under an existing DLA pharmaceutical distribution...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $33,928.08 to Amerisourcebergen Drug Corporation for the supply of 4561726200 OCREVUS 300 MG/10 ML VIAL 10ML. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period extending from August 7th through August 28th, 2023. The Defense Logistics Agency is the logistics combat support agency of the Department of Defense, responsible for worldwide logistics support in procurement,...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $45,237.44 to Amerisourcebergen Drug Corporation for the supply of 4562055207 Ocrevus 300 MG/10 ML Vials. Amerisourcebergen will deliver 10ML vials of the multiple sclerosis treatment Ocrevus to a location in Conshohocken, Pennsylvania under a start date of September 5, 2023 concluding on September 26, 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation. The...